MoneyWorks4Me

Indrayani Biotech informs about disclosures

01 Apr 2025 Evaluate
Indrayani Biotech has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 29, 2025 for Swaminathan Govindarajan.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Grasim Industries 2865.50
DCM Shriram 953.20
3M India 30307.30
Hindustan Foods 571.45
Balmer Lawrie & Co 157.25
View more..